FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to medicine, more specifically to pharmacology, neurology and cell engineering. What is described is using Napelline as a cerebroprotective agent. The mode of action of the agent is activation of cerebral neural stem cells.
EFFECT: invention achieves extending the range of high-effective cereroprotective agents.
3 tbl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
CEREBROPROTECTIVE AGENT | 2012 |
|
RU2501562C1 |
CEREBROPROTECTIVE AGENT | 2013 |
|
RU2517282C1 |
TISSUE REGENERATION STIMULATING AGENT | 2013 |
|
RU2599289C2 |
MEDICATION POSSESSING HAEMOSTIMULATING, ANTIMUTAGENIC, ANTITUMOUR, CEREBROPROTECTIVE, ANTIHYPOXIC, NOOTROPIC, ANXIOLYTIC AND ANTINEUROTIC ACTION | 2010 |
|
RU2438691C1 |
METHOD FOR CARRYING OUT EXPERIMENTAL ENCEPHALOPATHY THERAPY | 2004 |
|
RU2284060C1 |
AN ANTIHYPOXIC AGENT | 1996 |
|
RU2121357C1 |
MEDICATION FOR REGENERATIVE MEDICINE | 2009 |
|
RU2406528C2 |
DRUG POSSESSING REGENERATIVE ACTIVITY | 2011 |
|
RU2480236C1 |
METHOD FOR CONTROLLING ERYTHROPOIESIS DISORDERS IN EXPERIMENTAL ENCEPHALOPATHY CASES | 2005 |
|
RU2302664C2 |
AGENT SHOWING NOOTROPIC AND ADAPTOGENIC EFFECT | 1998 |
|
RU2136292C1 |
Authors
Dates
2013-11-10—Published
2012-10-08—Filed